Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00813-3Source: DataRank Database

Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel is a research paper published in Prostate Cancer and Prostatic Diseases (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times, with 4 citing works in its 1-hop citation network.

N/A

0.241DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access4 citations · 4 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT01809691

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.71)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.241

From this paper's citation signal

Citation Network Contribution

From 0 citing papers with measurable signal

This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.

Learn more about DataRank methodology →

Authors (15)

Edward Mayerson,Erik Gertz,Catherine M. Tangen ORCID,Amir Goldkorn ORCID,Marta Van Loan ORCID

Live enrichment

PubMed:38424319 PMC:PMC12036820 OpenAlex:https://openalex.org/W4392283080

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: CA180888

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: CA180819

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: CA093373

NCI NIH HHS

Grant: U10 CA180819

NCI NIH HHS

Grant: P30 CA093373

NCI NIH HHS

Grant: U10 CA180888

National Institutes of Health

Grant: 3U10CA180888-03S1

SWOG Network Group Operations Center of the NCTN

National Institutes of Health

Grant: 3P30CA093373-07S2

Cancer Center Support Grant - P30

National Institutes of Health

Grant: 2U10CA180819-06

SWOG Statistics and Data Management Center

Jerry and Susan Knapp

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Takeda Pharmaceuticals U.S.A.

FWCI

0.71

Citation Percentile

0.7%

Citation Trend

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12036820/pdf/nihms-2072823.pdf

publisherhttps://www.nature.com/articles/s41391-024-00813-3.pdf

publisherhttps://www.nature.com/articles/s41391-024-00813-3

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12036820

Fields of Study

Bone health and treatmentsProstate Cancer Treatment and ResearchMedical Imaging Techniques and Applications03 medical and health sciences0302 clinical medicine

MeSH Terms

AgedAndrogen AntagonistsBone and BonesBone NeoplasmsHumansMaleMiddle AgedPeptidesPrognosisProstatic NeoplasmsBiomarkers, TumorCollagen Type I

Keywords

MedicineProstate cancerOncologyInternal medicineAndrogen deprivation therapyBone remodelingAndrogenBone metastasisHormoneEndocrinologyCancerMaleProstatic NeoplasmsBone NeoplasmsAndrogen AntagonistsMiddle AgedPrognosisBone and BonesCollagen Type IBiomarkers, TumorHumansPeptidesAged

Sustainable Development Goals

SDG 0: Peace, Justice and strong institutions